MIT Researchers Develop Implantable Device to Combat Glioblastoma Recurrence
MIT researchers have designed an innovative implantable drug-delivery device...
MIT researchers have designed an innovative implantable drug-delivery device...
Moderna and Merck have announced results from a Phase 3 trial indicating that...
A recent clinical trial has demonstrated that a new personalized cancer...
In a promising development for small cell lung cancer treatment, Zai Lab...
A recent study shows that mRNA cancer vaccines, particularly a new personalized...
Indian researchers have introduced a promising cancer drug candidate, RK-251,...
Dattatreyudu Nori, a leading Indian-American radiation oncologist and 2026...
Recent research highlights promising early findings regarding an experimental...
A recent clinical trial indicates that low-dose aspirin may significantly...
As the patent for Merck & Co’s Keytruda nears expiration, at least...
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.